View of Adverse events of patients receiving rituximab, bevacizumab and omalizumab at King Chulalongkorn Memorial Hospital

Return to Article Details Adverse events of patients receiving rituximab, bevacizumab and omalizumab at King Chulalongkorn Memorial Hospital Download Download PDF